Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 33 min ago
Peer-reviewedCC BYCadernos de saude publica

Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.

  1. 1Universidade Federal da Paraíba, João Pessoa, Brasil.
  2. 2London School of Economics and Political Science, London, U.K.

Related

  1. Emerging Technologies in Granulation: Process Analytical Technologies and Modeling Approaches in Pharmaceutical Development and Manufacturing
    Panagiotis Pentsis, Maria Chountoulesi, Eirini Christodoulou +1
    PharmaceuticsPeer-reviewedCC BYFull textEurope PMC
  2. Flexible Printed RFID Tag Antennas for Scalable and Sustainable IoT: Design Physics, Manufacturing Technologies, and System-Level Validation
    Sensors (Basel, Switzerland)Peer-reviewedCC BYFull textEurope PMC
  3. Artificial Intelligence in Manufacturing Quality Assurance: Applications, Challenges, and Opportunities for Emerging Industrial Economies
    Arnold NIYONKURU, Arnold NIYONKURU
    ZenodoPreprintCC BY 4.0Full textZenodo
  4. Additive manufacturing of ceramic materials for energy applications: Road map and opportunities
    Corson L. Cramer, Emanuel Ionescu, Magdalena Graczyk-Zajac +12
    Journal of the European Ceramic SocietyPeer-reviewedLicence not stated186 citedMaterials & polymersHAL
  5. Finite Element Simulation of Microwave Technologies for PowderBased Volumetric Additive Manufacturing Processes
    Brendan Mackey, Levi Smith, Bosco Yu
    arXivPreprintCC BY 4.0Full textApplied physics & instrumentationarXiv
BibTeX
@article{menezes2026trump,
  title = {{Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.}},
  author = {Henrique Zeferino de Menezes and Kenneth C Shadlen},
  journal = {Cadernos de saude publica},
  year = {2026},
  month = oct,
  doi = {10.1590/0102-311xen052426},
  url = {https://europepmc.org/article/MED/42912037},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.
AU  - Henrique Zeferino de Menezes
AU  - Kenneth C Shadlen
PY  - 2026
DA  - 2026/10/12
JO  - Cadernos de saude publica
DO  - 10.1590/0102-311xen052426
UR  - https://europepmc.org/article/MED/42912037
SN  - 0102-311X
SN  - 1678-4464
ER  -